SAINTE-FOY, QUEBEC -- (MARKET WIRE) -- September 15, 2006 -- Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer and supplier of taxane APIs and developer of targeted oncology drugs, is pleased to announce manufacturing of the first industrial scale cGMP batch of its key intermediate for docetaxel.
